AIM ImmunoTech, Inc. (AIM)
1.18
+0.01
(+0.85%)
USD |
NYAM |
Jan 22, 10:01
AIM ImmunoTech Market Cap: 3.471M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.458B |
| Perspective Therapeutics, Inc. | 197.00M |
| Protalix Biotherapeutics, Inc. | 168.88M |
| Electromed, Inc. | 232.28M |
| Armata Pharmaceuticals, Inc. | 217.25M |
Market Cap Related Metrics
| PS Ratio | 194.40 |
| Price | 1.18 |
| Earnings Yield | -1.26K% |